IDIBELL-Bellvitge Biomedical Research Institute

Oncology & Cancer

Semen miRNAs could be non-invasive biomarkers for prostate cancer

Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service ...

Neuroscience

Apathy as an indicator of progression in Huntington's disease

Researchers from the brain cognition and plasticity group of the Bellvitge Biomedical Research Institute (IDIBELL) and the Neuroscience Institute of the University of Barcelona (UBNeuro) have led an innovative study that ...

Medical research

New treatment could improve care for two bone diseases

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) have described the ability of an inhibitor of the PI3Kα (BYL719) to block the ectopic bone formation in mice. This ...

Oncology & Cancer

An inflammatory diet correlates with colorectal cancer risk

Researchers from the Molecular Mechanisms and Experimental Therapy in Oncology program (Oncobell) of the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO), together with the Biodonostia ...

Oncology & Cancer

Researchers describe a new resistance mechanism

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) and the ProCure Program of the Catalan Institute of Oncology (ICO) published today inCancer Research a study describing a new mechanism in cancer that turns ...

page 3 from 14